title: National guidance on gynaecological cancer management: an audit of gynaecological cancer services and management in the South East of England.
abstract: OBJECTIVE
  To evaluate the appropriateness of the structure and the process of care for gynaecological cancer against national guidelines.
  
  
  METHODS
  Incident cases of ovarian and cervical cancer managed between 1 January, 1999 and 31 December, 2000 in the South East of England.
  
  
  METHODS
  Completion of an audit form, by a researcher, using the clinical record. Qualitative interviews with gynaecologists at each hospital.
  
  
  METHODS
  Whether hospitals meet the requirements for being a 'centre' or a 'unit' for gynaecological cancer and whether gynaecologists manage ovarian or cervical cancer according to the guidelines.
  
  
  RESULTS
  Stage was recorded in the notes of 53% (262/492) of women with ovarian cancer but information to assist in determining stage was recorded in 86%. Of women who had a stage recorded by the consultant, who should have had a laparotomy and be referred for chemotherapy, 81% (169/209) were managed according to the guidelines, ignoring whether there was removal of disease to nodules of less than 1 cm. Stage was recorded in the notes of 60% (188/315) of women with cervical cancer, although information relevant to staging the patient was recorded in 66%. Overall 76% (142/188) of women with stage recorded in the notes were managed according to the guidelines but 40% (127/315) of women audited were not assessable. Only one site met the criteria for being a cancer centre. Of the remaining sites, most striking was the inability to assemble a team of professionals, including a radiologist, a pathologist and an oncology nurse to discuss individual patient care.
  
  
  CONCLUSIONS
  Retrospective note audits will be hampered by missing data in the clinical record until systems are developed to improve the quality of notes. This research suggests that guidelines based on FIGO staging for the management of ovarian and cervical cancer are not followed and that this may be associated with incomplete cancer management teams.
authors.affiliation: Department of Public Health Sciences, The Guy's, King's College and St Thomas' Hospitals Schools of Medicine, Guy's Campus, London, UK.
authors.forename: M
authors.initials: M
authors.lastname: Shaw
authors.forename: C
authors.initials: C
authors.lastname: Wolfe
authors.forename: K S
authors.initials: KS
authors.lastname: Raju
authors.forename: A
authors.initials: A
authors.lastname: Papadopoulos
mesh_terms: D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D005833:Genital Neoplasms, Female / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D019983:Guideline Adherence; D006176:Gynecology / Q000592:standards; D019538:Health Care Surveys; D006801:Humans; D008485:Medical Audit; D008495:Medical Oncology / Q000592:standards*; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy; D017410:Practice Guidelines as Topic; D016019:Survival Analysis; D016896:Treatment Outcome; D006113:United Kingdom; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy